Herts and Essex Fertility - IVF Spot Purchase NCL ICB

NHS North Central London ICB has completed the procurement process for an In Vitro Fertilisation (IVF) spot purchase under the Health Care Services (Provider Selection Regime) Regulations 2023. The awarded contract is for the provision of fertility treatment services, specifically allowing patients a choice of providers, and is being fulfilled by Herts and Essex Fertility Centre Limited. The procurement took place without prior publication of a call for competition, and the contract was signed on 30th June 2025.

The services are categorised under in vitro fertilisation services with the location of service delivery centred in the UKH2 region. This procurement offers significant business growth opportunities, particularly for service providers specialising in healthcare and fertility treatments. By securing this contract, organisations can enhance their service delivery profile and expand their client base within the public healthcare system.

Businesses operating as small to medium-sized enterprises (SMEs) and capable of delivering specialised IVF services are well-suited to compete in similar opportunities. Additionally, participation in such procurement processes enables companies to gain a foothold in the public healthcare sector, which can lead to future tenders and contracts. Herts and Essex Fertility Centre Limited's successful bid highlights the potential for organisations with niche expertise to secure projects despite competitive dynamics.